Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations.
Journal: Cancer research
Published: December 05, 2019
Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors.
Journal: Journal for immunotherapy of cancer
Published: February 06, 2019
Showing 1-2 of 2
Last Updated: 09/26/2026